Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/103809
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHan, Nanyuen
dc.contributor.authorMu, Yuguangen
dc.date.accessioned2013-10-16T07:53:56Zen
dc.date.accessioned2019-12-06T21:20:46Z-
dc.date.available2013-10-16T07:53:56Zen
dc.date.available2019-12-06T21:20:46Z-
dc.date.copyright2013en
dc.date.issued2013en
dc.identifier.citationHan, N., & Mu, Y. (2013). Locking the 150-Cavity Open: In Silico Design and Verification of Influenza Neuraminidase Inhibitors. PLoS ONE, 8(8).en
dc.identifier.issn1932-6203en
dc.identifier.urihttps://hdl.handle.net/10356/103809-
dc.description.abstractNeuraminidase (NA) of influenza is a key target for virus infection control and the recently discovered open 150-cavity in group-1 NA provides new opportunity for novel inhibitors design. In this study, we used a combination of theoretical methods including fragment docking, molecular linking and molecular dynamics simulations to design ligands that specifically target at the 150-cavity. Through in silico screening of a fragment compound library on the open 150-cavity of NA, a few best scored fragment compounds were selected to link with Zanamivir, one NA-targeting drug. The resultant new ligands may bind both the active site and the 150-cavity of NA simultaneously. Extensive molecular dynamics simulations in explicit solvent were applied to validate the binding between NA and the designed ligands. Moreover, two control systems, a positive control using Zanamivir and a negative control using a low-affinity ligand 3-(p-tolyl) allyl-Neu5Ac2en (ETT, abbreviation reported in the PDB) found in a recent experimental work, were employed to calibrate the simulation method. During the simulations, ETT was observed to detach from NA, on the contrary, both Zanamivir and our designed ligand bind NA firmly. Our study provides a prospective way to design novel inhibitors for controlling the spread of influenza virus.en
dc.language.isoenen
dc.relation.ispartofseriesPLoS ONEen
dc.rights© 2013 Han et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en
dc.subjectDRNTU::Science::Biological sciences::Microbiologyen
dc.titleLocking the 150-cavity open : in silico design and verification of influenza neuraminidase inhibitorsen
dc.typeJournal Articleen
dc.contributor.schoolSchool of Biological Sciencesen
dc.identifier.doi10.1371/journal.pone.0073344en
dc.description.versionPublished versionen
item.fulltextWith Fulltext-
item.grantfulltextopen-
Appears in Collections:SBS Journal Articles

SCOPUSTM   
Citations 20

2
Updated on Mar 4, 2021

PublonsTM
Citations 50

1
Updated on Mar 7, 2021

Page view(s) 50

370
Updated on Jun 24, 2021

Download(s) 5

492
Updated on Jun 24, 2021

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.